Disclosure: This post may contain affiliate links. Purchases through these links support our site at no extra cost to you.
GLP-1 Goes Beyond Weight Loss
Drugs like Ozempic are reshaping how doctors treat chronic conditions in 2026.
Slide visual: Medical injection pen on blue background
Related Reading
Heart Health Gains
New studies show GLP-1s reduce major cardiac events in patients with heart disease.
Slide visual: Stethoscope on heart-shaped graphic
Kidney Disease Use
FDA expanded approvals to slow progression of chronic kidney disease in adults.
Slide visual: Anatomical kidney illustration
Addiction Research Surprises
Early trials hint GLP-1s may reduce cravings for alcohol and nicotine.
Slide visual: Brain scan with highlighted regions
What This Means for You
Talk to your doctor – eligibility is broader in 2026 than ever before.
Slide visual: Doctor consulting with patient at desk
Side Effects to Know
Nausea, fatigue, and slow stomach are common. Most fade in the first month.
Slide visual: Pill bottle with warning label
The Bigger Picture
GLP-1s may become the most-prescribed class of meds within five years.
Slide visual: Pharmacy shelf with stacked medications
GIPHY App Key not set. Please check settings